WuXi AppTec completes acquisition of AAV manufacturer Oxgene

Since its founding in 2011, Oxgene has offered discovery and biomanufacturing solutions to the cell and gene therapy industries through novel technologies and contract research solutions

picture of

Breaking News

Sartorius to open manufacturing facility in Hampshire

With the Havant facility, Sartorius now has five locations in the UK, employing over 900 staff members

Moderna and Catalent announce expanded vaccine collaboration

In September 2020, Catalent announced a $50 m investment into the third high-speed vial filling line at Bloomington. ...

Azzur completes second ready-to-use cleanroom facility in San Diego

US-based Azzur Cleanrooms on Demand has announced the completion of a build in San Diego that is the group's second ...

Five challenges for AAV developers

Bio-Rad experts Mark White, Associate Director of Biopharma Product Marketing, and Marwan Alsarraj, BioPharma Segment ...

Chime Biologics announces $190m funds to accelerate capacity expansion

The China-based CDMO has plans to increase the total manufacturing capacity to more than 140,000 L within the next 5 ...

Nanoform and Nacuity Pharmaceuticals sign Technology POC Agreement for two ophthalmic drug candidates

The agreement presents a unique opportunity to explore how nanoformed particles may enhance the performance of ...

Lessons learned from the COVID-19 pandemic

As vaccines roll out and COVID-19 cases begin to decline, Amélie Boulais, Head of Market Entry Strategy for Virus ...

Insilico and 2-control work towards the smart biofactory

The agreement follows Insilico's previous collaboration with Meyer Chroma Technology

Stablepharma and BB-NCIPD collaborating on Td vaccine

The companies are developing a version of BB-NCIPD’s Td vaccine using Stablepharma’s StabevaX technology

Towards the enzymatic synthesis of oligonucleotides: part II

By early 2020, ten oligonucleotide drugs had received US FDA regulatory approval; with many more in the pipeline, ...

From dark art to an age of enlightenment

Much is happening in the realms of Almac’s GMP peptides business in terms of growth, development and strategic ...

Why the production of bispecific antibodies depends on early stage product characterisation

Chloe Ackaert, Senior Scientist, and Sofie Pattijn, Chief Technology Officer and founder, ImmunXperts a Nexelis group ...

Sophia Genetics and Hitachi announce collaboration

Hitachi plans to broaden its healthcare business, leveraging the strengths of in-vitro diagnostics systems, particle ...

Nanoform launches next-generation STARMAP v2.0

The AI-based drug candidate selection tool for CESS allows reliable predictions to be made regarding partners potential ...